Retisert Implant in Noninfectious Uveitis

In this surgical video, Madison Whaley, Dr. Riley Sanders, and Dr. Ahmed Sallam demonstrate the technique of and highlight important key points for placement of a Retisert implant. Retisert is a 0.59-mg fluocinolone intravitreal implant used to treat chronic noninfectious uveitis affecting the posterior segment of the eye. This patient is a 67-year-old man with birdshot chorioretinopathy. He had a previous Retisert implant placed in the inferotemporal quadrant. This second implant was placed in the inferonasal quadrant via a scleral wound, which was then sewn up with both 8-0 and 9-0 polypropylene sutures (Prolene).

Relevant Financial Disclosures: None